Surgery Partners, Inc. (SGRY) Stock Price & Analysis

Surgery Partners, Inc. (SGRY) rose 3.35% to USD 15.73 as of July 25, 2026 at 03:08 UTC, according to Nexqual real-time market data.

SGRY last closed at USD 15.22; the session ranged USD 15.46–16.6 on volume of 4,092,677 shares. Market capitalization is $2.06B, with a 52-week range of USD 11.41–24.1 (NMS). Source: Nexqual, July 25, 2026 at 03:08 UTC.

Key Statistics (as of July 25, 2026 at 03:08 UTC)

PriceUSD 15.73
Change▲ 3.35% (up)
Previous CloseUSD 15.22
OpenUSD 15.64
Day RangeUSD 15.46 – 16.6
52-Week RangeUSD 11.41 – 24.1
Volume4,092,677 shares
Market Cap$2.06B
ExchangeNMS

Technical Analysis (SGRY)

Nexqual's technical model rates SGRY "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:08 UTC.

Overall SignalNEUTRAL
RSI (14)51.66 (neutral)
vs SMA50Above (USD 14.97)
MACD0.14 (positive)

Analyst Ratings (SGRY)

Wall Street analysts rate SGRY "Buy" based on 11 analysts, with a mean price target of USD 18.64 (range USD 14–24), per Nexqual as of July 25, 2026 at 03:08 UTC.

Consensus RatingBuy
Analyst Count11
Mean TargetUSD 18.64
High TargetUSD 24
Low TargetUSD 14
Buy / Hold / Sell9 / 3 / 0

Earnings (SGRY)

Next Earnings Date2026-08-10
EPS EstimateUSD 0.07
Revenue Estimate$830.32M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.03 vs est -0.14 ▲ beat
2025-12-31USD 0.12 vs est 0.3 ▼ miss
2025-09-30USD 0.13 vs est 0.16 ▼ miss
2025-06-30USD 0.17 vs est 0.14 ▲ beat

Source: Nexqual, July 25, 2026 at 03:08 UTC.

Financials & Fundamentals (SGRY)

Total Revenue$3.34B
Revenue Growth (YoY)+4.50%
Gross Margin+22.83%
Operating Margin+10.37%
Profit Margin-2.28%
ROE+2.75%
Debt / Equity116.01
Current Ratio1.86
Total Cash$182.30M
Total Debt$4.04B
Free Cash Flow$199.06M

Source: Nexqual, July 25, 2026 at 03:08 UTC.

Financial Health Score (SGRY)

Nexqual rates Surgery Partners, Inc.'s overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:08 UTC.

GrowthSolid — Revenue +6% YoY (annual)
ProfitabilityMixed — Gross margin 23%, operating 10%
Balance SheetMixed — $182M cash vs $4.04B debt
Cash FlowSolid — FCF $199M, 6% margin
EfficiencyWeak — ROE 3%, ROA 3.7%

Ownership (SGRY)

Insider Ownership+1.79%
Institutional Ownership+123.30%
Shares Outstanding130.79M
Float54.13M
Short % of Float+22.94%

Source: Nexqual, July 25, 2026 at 03:08 UTC.

Leadership (SGRY)

Surgery Partners, Inc. is led by J. Eric Evans (age 48), CEO & Director, per Nexqual as of July 25, 2026 at 03:08 UTC.

CEO & DirectorJ. Eric Evans (age 48)
Executive VP & CFODavid T. Doherty (age 53)
Executive VP & Chief Strategy OfficerMarissa A. Brittenham (age 40)
President of American GroupW. Trent Webb (age 45)
Executive Vice President, COO & National Group PresidentJustin R. Oppenheimer (age 40)

Major Backers & Investors (SGRY)

Notable institutional backers of Surgery Partners, Inc. include Bain Capital Investors Llc, Janus Henderson Group PLC, JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund, according to Nexqual as of July 25, 2026 at 03:08 UTC.

Active Investors

InvestorStake
Bain Capital Investors Llc38.19%
Janus Henderson Group PLC10.35%
JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund9.92%
Pentwater Capital Management Lp9.68%
King Street Capital Management, LP7.82%
UBS Group AG7.79%
ClearBridge Investments, LLC3.15%

Index Funds (Passive)

FundStake
Vanguard Group9.5%
BlackRock5.74%
Dimensional Fund Advisors4.05%

Source: Nexqual, July 25, 2026 at 03:08 UTC.

From Surgery Partners, Inc.'s Latest SEC 10-K Filing (filed 2026-03-02)

Key Strengths & Strategy (as disclosed to the SEC)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
LIVNLivaNova PLCUSD 78.19▼ 0.1%
OPCHOption Care Health, Inc.USD 21.66▲ 2.41%
EVHEvolent Health, IncUSD 4.22▼ 24.24%
PRVAPrivia Health Group, Inc.USD 25.5▲ 0.51%
ACHCAcadia Healthcare Company, Inc.USD 34.51▼ 0.78%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:08 UTC. This page is informational and not investment advice.